NASDAQ:ONTX

Onconova Therapeutics Earnings Date, Estimates & Call Transcripts (2022)

$1.28

+0.03 (+2.40%)

(As of 06/24/2022 12:00 AM ET)

Add

Compare

Today's Range: $1.25
▼
$1.30
50-Day Range: $1.04
▼
$1.51
52-Week Range: $1.00
▼
$7.48

Volume: 93,987 shs
Average Volume: 114,424 shs
Market Capitalization: $26.75 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $10.00

Upcoming Earnings Date: Aug. 11Estimated
Actual EPS (May. 11): -$0.20 Missed By -$0.02
Consensus EPS (May. 11): -$0.18
Last Year's Q2 EPS (5/17/2021): -$0.30

Read Call Transcript

Listen to Call

Earnings Per Share Revenue

ONTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ONTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Onconova Therapeutics Earnings Estimates

Current Year EPS Consensus Estimate: $-0.79 EPS
Next Year EPS Consensus Estimate: $-0.74 EPS

ONTX Earnings Date and Information

Onconova Therapeutics last released its quarterly earnings data on May 11th, 2022. The biopharmaceutical company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.18) by $0.02. The company had revenue of $0.06 million for the quarter, compared to the consensus estimate of $0.06 million. Onconova Therapeutics has generated ($0.85) earnings per share over the last year (($0.85) diluted earnings per share). Earnings for Onconova Therapeutics are expected to grow in the coming year, from ($0.79) to ($0.74) per share. Onconova Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off prior year's report dates.

Onconova Therapeutics Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/11/2022 (Estimated)
5/11/2022	Q1 2022	($0.18)	($0.20)	($0.02)	($0.20)	$0.06 million	$0.06 million
3/17/2022	Q4 2021		($0.16)	($0.16)	($0.16)	$0.08 million	$0.06 million
11/11/2021	9/30/2021	($0.33)	($0.22)	+$0.11	($0.22)	$0.06 million	$0.06 million
8/12/2021	6/30/2021	($0.28)	($0.27)	+$0.01	($0.27)	$0.04 million	$0.06 million
5/17/2021	3/31/2021	($0.45)	($0.30)	+$0.15	($0.02)	$0.06 million	$0.06 million
3/11/2021	12/31/2020	($0.60)	($0.45)	+$0.15	($0.03)	$0.05 million	$0.06 million
11/12/2020	9/30/2020	($0.30)	($0.45)	($0.15)	($0.03)	$4.10 million	$0.07 million
8/12/2020	6/30/2020	($0.45)	($0.60)	($0.15)	($0.04)	$0.40 million	$0.06 million
5/14/2020	3/31/2020	($0.60)	($0.45)	+$0.15	($0.03)	$0.10 million	$0.05 million
11/12/2019	Q3 2019	($11.40)	($11.25)	+$0.15	($0.75)	$0.31 million	$0.06 million

8/14/2019	Q2 2019	($14.70)	($9.00)	+$5.70	($0.60)	$0.25 million	$2.02 million
5/14/2019	3/31/2019	($16.65)	($19.35)	($2.70)	($1.29)	$0.08 million	$0.07 million
3/26/2019	12/31/2018	($16.35)	($12.75)	+$3.60	($0.85)	$0.22 million	$0.06 million
11/13/2018	Q3	($11.70)	($14.10)	($2.40)	($0.94)	$1.87 million	$0.12 million
8/14/2018	Q2 2018	($18.00)	($15.75)	+$2.25	($0.09)	$0.52 million	$0.49 million
5/15/2018	Q1 2018	($87.75)	($76.50)	+$11.25	($0.34)	$0.48 million	$0.56 million
3/8/2018	Q4 2017	($155.25)	($132.75)	+$22.50	($0.59)	$0.31 million	$0.14 million
11/9/2017	Q3 2017	($164.25)	($159.75)	+$4.50	($0.71)	$0.29 million	$0.11 million
8/14/2017	Q2 2017	($162.00)	($65.25)	+$96.75	($0.29)	$0.25 million	$0.32 million
5/15/2017	Q1 2017	($216.00)	($276.75)	($60.75)	($1.23)		$0.21 million
3/27/2017	Q4 2016		($121.50)	($121.50)	($0.54)		$0.17 million
11/14/2016	Q3 2016		($64.95)	($64.95)	($4.33)	$1.60 million	$1.70 million
8/15/2016	Q2 2016		($438.75)	($438.75)	($29.25)		$2.25 million
5/11/2016	Q1 2016	($425.40)	($604.50)	($179.10)	($40.30)	$1.34 million	$1.47 million
3/28/2016	Q4 2015		$403.05	+$403.05	$26.87		$9.60 million
11/11/2015	Q3 2015	($649.20)	($582.15)	+$67.05	($38.81)	$0.11 million	$1.62 million
8/13/2015	Q2 2015	($1,253.70)	($917.85)	+$335.85	($61.19)	$0.11 million	$0.12 million
5/14/2015	Q1 2015	($1,410.45)	($1,276.05)	+$134.40	($85.07)	$0.11 million	$0.11 million
3/26/2015	Q4 2014	($1,589.55)	($1,388.10)	+$201.45	($92.54)		$0.11 million
11/13/2014	Q3 2014	($1,746.30)	($1,544.85)	+$201.45	($102.99)		$0.11 million
8/13/2014	Q2 2014	($1,992.60)	($1,723.95)	+$268.65	($114.93)	$0.56 million	$0.13 million
5/12/2014	Q1 2014	($1,746.30)	($1,947.75)	($201.45)	($129.85)	$1.32 million	$0.45 million
3/10/2014	Q4 2013	($2,194.05)	($1,522.35)	+$671.70	($101.49)	$1.07 million	$1.93 million
11/12/2013	Q3 2013	($1,746.30)	($3,000.00)	($1,253.70)	($200.00)	$1.07 million	$1.12 million
9/6/2013	Q2 2013	($1,746.30)	($11,664.15)	($9,917.85)	($777.61)	$0.22 million	$0.59 million

Onconova Therapeutics Earnings - Frequently Asked Questions

When is Onconova Therapeutics's earnings date?: Onconova Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 11th, 2022 based off last year's report dates. Learn more on ONTX's earnings history.
Did Onconova Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Onconova Therapeutics (NASDAQ:ONTX) missed the analysts' consensus estimate of ($0.18) by $0.02 with a reported earnings per share (EPS) of ($0.20). Learn more on analysts' earnings estimate vs. ONTX's actual earnings.
How can I listen to Onconova Therapeutics's earnings conference call?: The conference call for Onconova Therapeutics's latest earnings report can be listened to online. Listen to Conference Call
How can I read Onconova Therapeutics's conference call transcript?: The conference call transcript for Onconova Therapeutics's latest earnings report can be read online. Read Transcript

How much revenue does Onconova Therapeutics generate each year?: Onconova Therapeutics (NASDAQ:ONTX) has a recorded annual revenue of $230 thousand.
How much profit does Onconova Therapeutics generate each year?: Onconova Therapeutics (NASDAQ:ONTX) has a recorded net income of -$16.16 million. ONTX has generated -$0.85 earnings per share over the last four quarters.
What is Onconova Therapeutics's EPS forecast for next year?: Onconova Therapeutics's earnings are expected to grow from ($0.79) per share to ($0.74) per share in the next year.

This page (NASDAQ:ONTX) was last updated on 6/26/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources